Story perspectives

Advocates Call for FDA Oversight on Transfeminine Hormone Access

4/18/2026

Summary

Story summary

Transfeminine individuals in the Philippines have historically used female birth control for hormone transition, despite risks.
The Do No Harm report advocates more FDA oversight, arguing it targets adults under the guise of child safety.
Pressure from pharmaceutical companies and anti-trans groups threatens DIY HRT resources, a concern reflected by scrutiny of HRTCafe.net.
Users should research and consult their community for safe practices while recognizing unregulated pharmacies provide affordable medications.

1 of 1

Story summary

Transfeminine individuals in the Philippines have historically used female birth control for hormone transition, despite risks.
The Do No Harm report advocates more FDA oversight, arguing it targets adults under the guise of child safety.
Pressure from pharmaceutical companies and anti-trans groups threatens DIY HRT resources, a concern reflected by scrutiny of HRTCafe.net.
Users should research and consult their community for safe practices while recognizing unregulated pharmacies provide affordable medications.